Table 2.
Values in the male patients and controls.
| Male | ||||||
|---|---|---|---|---|---|---|
| Severe N = 53 |
Mild N = 72 |
p | Covid N = 125 |
Control N = 248 |
p | |
| Mean age | 67.19 | 63.89 | 0.13 | 64.77 | 70.01 | AV |
| Hypertensives | 34 (64%) | 26 (36%) | 0.002 | 60 (48%) | 97 (39%) | 0.10 |
| Diabetics | 12 (23%) | 12 (17%) | 0.42 | 24 (19%) | 47 (19%) | 1 |
| Hiperlchols | 25 (47%) | 18 (25%) | 0.01 | 43 (34%) | 82 (33%) | 0.79 |
| ACE2# | ||||||
| G | 43 (81%) | 58 (81%) | 0.92 | 101 (81%) | 200 (85%) | 0.25 |
| A | 10 (19%) | 14 (19%) | 24 (19%) | 34 (15%) | ||
| ACE I/D | ||||||
| DD | 28 (53%) | 25 (35%) | 0.043* | 53 (42%) | 85 (34%) | 0.13 |
| ID | 23 (43%) | 43 (60%) | 66 (53%) | 123 (50%) | ||
| II | 2 (4%) | 4 (5%) | 6 (5%) | 40 (16%) | ||
AV: adjust variable, #234 male controls genotyped.
* DD vs ID + II.